| Literature DB >> 28733313 |
Zia U A Mollah1, Hong Sheng Quah1,2, Kate L Graham1,2, Gaurang Jhala1,2, Balasubramanian Krishnamurthy1,2, Joanna Francisca M Dharma1,2, Jonathan Chee1,2, Prerak M Trivedi1,2, Evan G Pappas1, Leanne Mackin1, Edward P F Chu1,2, Satoru Akazawa1, Stacey Fynch1, Charlotte Hodson1, Andrew J Deans1,2, Joseph A Trapani3, Mark M W Chong1,2, Phillip I Bird4, Thomas C Brodnicki1,2, Helen E Thomas1,2, Thomas W H Kay5,2.
Abstract
Granzyme A is a protease implicated in the degradation of intracellular DNA. Nucleotide complexes are known triggers of systemic autoimmunity, but a role in organ-specific autoimmune disease has not been demonstrated. To investigate whether such a mechanism could be an endogenous trigger for autoimmunity, we examined the impact of granzyme A deficiency in the NOD mouse model of autoimmune diabetes. Granzyme A deficiency resulted in an increased incidence in diabetes associated with accumulation of ssDNA in immune cells and induction of an interferon response in pancreatic islets. Central tolerance to proinsulin in transgenic NOD mice was broken on a granzyme A-deficient background. We have identified a novel endogenous trigger for autoimmune diabetes and an in vivo role for granzyme A in maintaining immune tolerance.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28733313 DOI: 10.2337/db17-0517
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461